Marizomib for central nervous system-multiple myeloma

被引：62

作者：

Badros, Ashraf ^{[1
]}

Singh, Zeba ^{[1
]}

Dhakal, Binod ^{[2
]}

Kwok, Young ^{[1
]}

MacLaren, Ann ^{[3
]}

Richardson, Paul ^{[4
]}

Trikha, Mohit ^{[3
]}

Hari, Parameswaran ^{[2
]}

机构：

[1] Univ Maryland, Med Ctr, M&S Greenebaum Canc Ctr, Baltimore, MD 21201 USA

[2] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI 53226 USA

[3] Triphase Accelerator, San Diego, CA USA

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 177卷 / 02期

关键词：

multiple myeloma; central nervous system relapse; clinical studies; marizomib; INVOLVEMENT;

D O I：

10.1111/bjh.14498

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Marizomib, a natural marine product, is an irreversible proteasome inhibitor currently under investigation in relapsed-refractory multiple myeloma (RRMM) and malignant glioma. Central nervous system-multiple myeloma (CNS-MM) is a rare manifestation of extra-medullary disease with few therapeutic options, highlighting the unmet clinical need in these patients. Marizomib demonstrated encouraging activity in RRMM and has emerging clinical activity in glioma, making it a potential CNS-MM therapeutic intervention. Herein, we present two patients with RRMM and CNS involvement who benefited from marizomib-based therapy. Thesecases provide the first proof of principle for further exploring marizomib in CNS-MM patients.

引用

页码：221 / 225

页数：5

共 50 条

[11] Multiple myeloma with central nervous system involvement in a cat
Appel, Sherry L.
Moens, Noel M. M.
Abrams-Ogg, Anthony C. G.
Woods, J. Paul
Nykamp, Stephanie
Bienzle, Dorothee
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2008, 233 (05): : 743 - 747
[12] CUTANEOUS AND CENTRAL NERVOUS SYSTEM INVOLVEMENT IN MULTIPLE MYELOMA
Karam, S.
Matushansky, I.
Hassoun, H.
JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 304 - 304
[13] Marizomib for CNS-Multiple Myeloma
Badros, Ashraf Z.
Singh, Zeba
Dhakal, Binod
Kwok, Young
MacLaren, Ann
Richardson, Paul G.
Trikha, Mohit
Parameswaran, Hari
BLOOD, 2016, 128 (22)
[14] Multiple myeloma with central nervous system relapse: a case report
Marics, Petra
Pokieser, Wolfgang
Neubauer, Nikolaus
Slavka, Georg
Hilbe, Wolfgang
Schreder, Martin
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2022, 15 (03) : 243 - 245
[15] Characteristics of multiple myeloma patients with central nervous system involvement
Chen, Jessica
Richards, Tiffany
Allen, Christy
Jiang, Yue
Bendig, Courtney
Morphey, Ashley
Cuellar, Elizabeth
Knight, Sarah
Ighovoyivwi, Efe
Lu, Rebecca
Lin, Pei
Amini, Behrang
Gaballa, Mahmoud
Lee, Hans
Manasanch, Elisabet
Patel, Krina
Thomas, Sheeba
Ye, Jing Christine
Dabaja, Bouthain
Pinnix, Chelsea
Fang, Penny
Gunther, Jill
Orlowski, Robert
Weber, Donna
Becnel, Melody
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S310 - S310
[16] Central nervous system multiple myeloma: a different cytogenetic profile
Gozzetti, Alessandro
Frasconi, Adele
Crupi, Rosaria
Candi, Veronica
Defina, Marzia
Bocchia, Monica
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 889 - 890
[17] Central Nervous System Relapse of Multiple Myeloma: A Case Report
Zafar, Maha
Reddy, Aswanth
Kumar, Swarup
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S552 - S553
[18] Central nervous system multiple myeloma: a different cytogenetic profile?
Chang, Won Jin
Kim, Seok Jin
Kim, Kihyun
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) : 745 - 748
[19] Central nervous system findings in 65 multiple myeloma autopsies
Tyler, LN
Joseph, L
Waldron, JA
Hough, AJ
Barlogie, B
Gokden, M
MODERN PATHOLOGY, 2002, 15 (01) : 9A - 9A
[20] Central nervous system (CNS) involvement in multiple myeloma (MM).
Fassas, A
Muwalla, F
Bemradane, R
Badros, A
Toor, A
Zangari, M
Morris, C
Anaissie, E
Mathew, S
Joseph, L
Barlogie, B
Tricot, G
BLOOD, 2001, 98 (11) : 297B - 297B

← 1 2 3 4 5 →